Literature DB >> 8954037

Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians.

R A Hegele1, S B Harris, A J Hanley, S Sadikian, P W Connelly, B Zinman.   

Abstract

We hypothesized that genomic variation affecting the primary amino acid sequence of the intestinal fatty acid-binding protein would be related to variation in body mass index and associated clinical phenotypes in aboriginal Canadians. We studied 507 adult native Canadians from an isolated community in Northern Ontario. We found that the frequency of the T54 variant of the intestinal fatty acid-binding protein gene was 0.14 in this sample. The presence of this variant was associated with significant increases in body mass index, percent body fat, and fasting plasma triglyceride concentration (P = 0.012, 0.019, and 0.012, respectively). However, the variant was not associated with the presence of diabetes mellitus. These findings suggest that the T54 variant of the intestinal fatty acid-binding protein is associated with differences in fat metabolism in this aboriginal population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954037     DOI: 10.1210/jcem.81.12.8954037

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.

Authors:  Michael Miller; Jeffrey Rhyne; Hegang Chen; Valerie Beach; Richard Ericson; Kalpana Luthra; Manjari Dwivedi; Anoop Misra
Journal:  Arch Med Res       Date:  2007-03-26       Impact factor: 2.235

Review 3.  New insights into the fatty acid-binding protein (FABP) family in the small intestine.

Authors:  Philippe Besnard; Isabelle Niot; Hélène Poirier; Lionel Clément; André Bernard
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

4.  Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels.

Authors:  Coleen M Damcott; Eleanor Feingold; Susan P Moffett; M Michael Barmada; Julie A Marshall; Richard F Hamman; Robert E Ferrell
Journal:  Hum Genet       Date:  2003-03-13       Impact factor: 4.132

Review 5.  The human fatty acid-binding protein family: evolutionary divergences and functions.

Authors:  Rebecca L Smathers; Dennis R Petersen
Journal:  Hum Genomics       Date:  2011-03       Impact factor: 4.639

Review 6.  Genetic predictors of plasma lipid response to diet intervention.

Authors:  J M Ordovas; J R Galluzzi
Journal:  Curr Atheroscler Rep       Date:  1999-11       Impact factor: 5.967

7.  The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians.

Authors:  K C Chiu; L M Chuang; C Yoon
Journal:  BMC Genet       Date:  2001-03-28       Impact factor: 2.797

Review 8.  Association of genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus.

Authors:  Shania Abbas; Syed Tasleem Raza; Faisal Ahmed; Absar Ahmad; Saliha Rizvi; Farzana Mahdi
Journal:  J Biomed Sci       Date:  2013-10-25       Impact factor: 8.410

9.  Polymorphism of the FABP2 gene: a population frequency analysis and an association study with cardiovascular risk markers in Argentina.

Authors:  Laura C Gomez; Sebastián M Real; Marta S Ojeda; Sergio Gimenez; Luis S Mayorga; María Roqué
Journal:  BMC Med Genet       Date:  2007-06-26       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.